BRAIN Biotech AG (ETR:BNN)
Germany · Delayed Price · Currency is EUR 3.020
+0.060 (2.03%)
May 25, 2026, 5:35 PM CET
BRAIN Biotech AG Market Cap
BRAIN Biotech AG has a market cap or net worth of €64.67 million as of May 22, 2026. Its market cap has increased by 43.00% in one year.
Market Cap
64.67M
Enterprise Value
59.52M
Revenue
49.01M
Ranking
n/a
PE Ratio
n/a
Stock Price
€3.02
Market Cap Chart
Since February 9, 2016, BRAIN Biotech AG's market cap has decreased from 149.34M to 64.67M, a decrease of -56.70%. That is a compound annual growth rate of -7.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 22, 2026 | 64.67M | 17.46% |
| Dec 30, 2025 | 55.06M | -29.01% |
| Dec 30, 2024 | 77.56M | -3.01% |
| Dec 29, 2023 | 79.96M | -37.33% |
| Dec 30, 2022 | 127.59M | -37.20% |
| Dec 30, 2021 | 203.18M | 13.16% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Evonik Industries AG | 8.05B |
| Wacker Chemie AG | 5.05B |
| Fuchs SE | 4.50B |
| Verbio SE | 2.42B |
| AlzChem Group AG | 1.68B |
| LANXESS Aktiengesellschaft | 1.45B |
| Uzin Utz SE | 322.84M |
| H&R GmbH & Co. KGaA | 173.08M |